Eczacıbaşı to acquire Turkish pharma company Gensenta for $135m
Following the acquisition, Amgen Turkey will maintain its operations and serve its patients in the region.
News
Latest in
News
HDT Bio receives Emergency Use Approval for Covid-19 vaccine in India
Gemcovac became the first saRNA vaccine to obtain approval for use in humans in India.
Pfizer and BioNTech enter $3.2bn deal with US Government for Covid-19 shots
This deal might comprise Omicron-adapted Covid-19 vaccines contingent on obtaining the US FDA authorisation.
Japan’s MHLW accepts GSK’s submission for shingles vaccine in adults
The filing is based on data from six clinical trials in subjects of the age 18 years and above.
EC grants approval for Kite’s cell therapy to treat follicular lymphoma
The latest approval is based on findings from the Phase II ZUMA-5 trial in 122 relapsed or refractory FL patients.
Terumo and GenCure sign agreement for cell and gene therapies
The alliance will use Terumo and GenCure’s capabilities to set up a reference manufacturing centre for BioBridge Global.
Astellas and Sutro partner to develop immunostimulatory ADCs
Sutro could be eligible for milestone payments of up to $422.5m for each product candidate.
EMA CHMP recommends AstraZeneca-Merck’s Lynparza for breast cancer
The latest development is based on findings from the global Phase III OlympiA trial of Lynparza.